HRP20181316T1 - Tehnologija isporuke lijeka - Google Patents
Tehnologija isporuke lijekaInfo
- Publication number
- HRP20181316T1 HRP20181316T1 HRP20181316TT HRP20181316T HRP20181316T1 HR P20181316 T1 HRP20181316 T1 HR P20181316T1 HR P20181316T T HRP20181316T T HR P20181316TT HR P20181316 T HRP20181316 T HR P20181316T HR P20181316 T1 HRP20181316 T1 HR P20181316T1
- Authority
- HR
- Croatia
- Prior art keywords
- drug delivery
- delivery technology
- technology
- drug
- delivery
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Dispersion Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1122041.5A GB2497933B (en) | 2011-12-21 | 2011-12-21 | Drug delivery technology |
| PCT/GB2012/053184 WO2013093456A1 (en) | 2011-12-21 | 2012-12-19 | Drug delivery technology |
| EP12806098.5A EP2793857B1 (en) | 2011-12-21 | 2012-12-19 | Drug delivery technology |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20181316T1 true HRP20181316T1 (hr) | 2018-10-19 |
Family
ID=45572816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20181316TT HRP20181316T1 (hr) | 2011-12-21 | 2018-08-16 | Tehnologija isporuke lijeka |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20150005307A1 (hr) |
| EP (1) | EP2793857B1 (hr) |
| JP (1) | JP2015511213A (hr) |
| AU (1) | AU2012370410A1 (hr) |
| CY (1) | CY1120648T1 (hr) |
| DK (1) | DK2793857T3 (hr) |
| ES (1) | ES2684491T3 (hr) |
| GB (1) | GB2497933B (hr) |
| HR (1) | HRP20181316T1 (hr) |
| HU (1) | HUE039907T2 (hr) |
| LT (1) | LT2793857T (hr) |
| PL (1) | PL2793857T3 (hr) |
| PT (1) | PT2793857T (hr) |
| RS (1) | RS57629B1 (hr) |
| SI (1) | SI2793857T1 (hr) |
| WO (1) | WO2013093456A1 (hr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150099751A1 (en) * | 2013-10-07 | 2015-04-09 | King Abdulaziz University | In situ gel loaded with phosphodiesterase type v inhibitors nanoemulsion |
| NO2723977T3 (hr) | 2014-03-19 | 2018-03-10 | ||
| KR101617379B1 (ko) * | 2015-05-13 | 2016-05-02 | 주식회사 삼양사 | 혼합당 과립 분말 및 이의 제조방법 |
| BR102015020720A2 (pt) * | 2015-08-27 | 2017-03-01 | Henrique Leonardo Pereira Luis | composição hidrofíilica atóxica, bioidêntica e biodegradável à base de partículas micronizadas de acido hialurônico, com propriedades mucoadesivas e carreadoras via transmucosa aglutinadas por bioengenharia a um ipde5, para tratamento de disfunção erétil, com aplicação em sistema de spray de aerossol sublingual |
| KR20210132740A (ko) * | 2019-03-24 | 2021-11-04 | 주식회사 아리바이오 | 아밀로이드 베타 형성을 줄이기 위한 방법 및 이를 위한 조성물 |
| CN116687888A (zh) * | 2023-06-02 | 2023-09-05 | 苏州易合医药有限公司 | 伐地那非和达泊西汀复方干粉吸入制剂及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI223598B (en) * | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
| US6200591B1 (en) * | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
| DE19834506A1 (de) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Transmucosales therapeutisches System zur Anwendung von Sildenafil |
| AU3048501A (en) * | 1999-11-18 | 2001-05-30 | Natco Pharma Limited | An improved pharmaceutical composition for treating male erectile dysfunction |
| AU2001273545A1 (en) * | 2000-07-19 | 2002-01-30 | Lavipharm Laboratories, Inc. | Sildenafil citrate solid dispersions having high water solubility |
| US20060035905A1 (en) * | 2004-02-06 | 2006-02-16 | Becton, Dickinson And Company | Formulations of phosphodiesterase 5 inhibitors and methods of use |
| DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
| US20070249640A1 (en) * | 2005-06-16 | 2007-10-25 | Myriad Genetics, Incorporated | Pharmaceutical compositions and use thereof |
| EP1898879A1 (en) * | 2005-06-23 | 2008-03-19 | Schering Corporation | Rapidly absorbing oral formulations of pde5 inhibitors |
| FR2906140B1 (fr) * | 2006-09-22 | 2008-12-05 | Philippe Perovitch | Forme galenique pour l'administration par voie trans-muqueuse de principes actifs |
| US20110263606A1 (en) * | 2010-04-26 | 2011-10-27 | Horst Zerbe | Solid oral dosage forms comprising tadalafil |
| US20130143894A1 (en) * | 2010-06-07 | 2013-06-06 | vadel Pharma Inc. | Oral spray formulations ad methods for administration of sildenafil |
-
2011
- 2011-12-21 GB GB1122041.5A patent/GB2497933B/en not_active Expired - Fee Related
-
2012
- 2012-12-19 ES ES12806098.5T patent/ES2684491T3/es active Active
- 2012-12-19 HU HUE12806098A patent/HUE039907T2/hu unknown
- 2012-12-19 US US14/367,312 patent/US20150005307A1/en not_active Abandoned
- 2012-12-19 PL PL12806098T patent/PL2793857T3/pl unknown
- 2012-12-19 WO PCT/GB2012/053184 patent/WO2013093456A1/en active Application Filing
- 2012-12-19 EP EP12806098.5A patent/EP2793857B1/en active Active
- 2012-12-19 AU AU2012370410A patent/AU2012370410A1/en not_active Abandoned
- 2012-12-19 PT PT12806098T patent/PT2793857T/pt unknown
- 2012-12-19 DK DK12806098.5T patent/DK2793857T3/en active
- 2012-12-19 RS RS20180961A patent/RS57629B1/sr unknown
- 2012-12-19 SI SI201231365T patent/SI2793857T1/sl unknown
- 2012-12-19 JP JP2014548187A patent/JP2015511213A/ja active Pending
- 2012-12-19 LT LTEP12806098.5T patent/LT2793857T/lt unknown
-
2018
- 2018-08-16 HR HRP20181316TT patent/HRP20181316T1/hr unknown
- 2018-08-31 CY CY181100909T patent/CY1120648T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1120648T1 (el) | 2019-12-11 |
| EP2793857B1 (en) | 2018-06-13 |
| JP2015511213A (ja) | 2015-04-16 |
| HUE039907T2 (hu) | 2019-02-28 |
| PT2793857T (pt) | 2018-10-19 |
| GB2497933A (en) | 2013-07-03 |
| EP2793857A1 (en) | 2014-10-29 |
| GB2497933B (en) | 2014-12-24 |
| DK2793857T3 (en) | 2018-08-20 |
| SI2793857T1 (sl) | 2018-10-30 |
| ES2684491T3 (es) | 2018-10-03 |
| PL2793857T3 (pl) | 2018-12-31 |
| GB201122041D0 (en) | 2012-02-01 |
| WO2013093456A1 (en) | 2013-06-27 |
| US20150005307A1 (en) | 2015-01-01 |
| LT2793857T (lt) | 2018-12-10 |
| AU2012370410A1 (en) | 2013-09-19 |
| RS57629B1 (sr) | 2018-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201401851UA (en) | Methods for drug delivery | |
| IL232768A0 (en) | A drug delivery device | |
| ZA201307378B (en) | Medicament delivery device | |
| EP2683431A4 (en) | DRUG DELIVERY SYSTEM | |
| IL227712A0 (en) | Device for sending medicine | |
| EP2739341A4 (en) | Microfluidic release agents | |
| EP2793953A4 (en) | TELODENDRIMERS WITH INCREASED DRUG DELIVERY | |
| EP2683328A4 (en) | ADMINISTRATION SYSTEM | |
| EP2680913A4 (en) | DEVICE FOR NASAL ACTIVE INFUSION | |
| EP2665431C0 (en) | DRUG DELIVERY TECHNOLOGY | |
| GB201121069D0 (en) | Delivery system | |
| GB2490770B (en) | Drug delivery inhaler devices | |
| ZA201306604B (en) | Drug delivery device | |
| HRP20181316T1 (hr) | Tehnologija isporuke lijeka | |
| EP2788053A4 (en) | DEVICE FOR DELIVERING MEDICAMENTS | |
| ZA201309156B (en) | Drug delivery system | |
| HK1206292A1 (en) | Medicament administration | |
| IL236757A0 (en) | A device for administering a drug with retention in the digestive system | |
| EP2756856A4 (en) | DRUG INFUSION SYSTEM | |
| GB201110632D0 (en) | Drug delivery formulations | |
| EP2687212A4 (en) | DRUG AGENT | |
| EP2667917A4 (en) | REMOVABLE DEVICE FOR DRUG DELIVERY | |
| GB201121693D0 (en) | Medicament delivery technology | |
| GB201107478D0 (en) | Nasal delivery | |
| GB201107477D0 (en) | Nasal delivery |